chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complained of dizziness on walking to the car. Pt. Brought back inside and watched in private area by EMT. Patient dismissed at 17:25 p.m. Patient seen by EMT on site.
This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Napped for 3 hours), TACHYCARDIA (Heart rate was Tachycardia at 100 beat per minutes), DIARRHOEA (Explosive diarrhea compared to colonoscopy prep/Loose stool every 3 hours), PAIN IN EXTREMITY (he had pain in his arm of injection) and FATIGUE (he was very tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Cold (cold(upper respiratory tract infection) lasted 10 days) from 01-Jan-2021 to January 2021. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced SOMNOLENCE (Napped for 3 hours) and FATIGUE (he was very tired). On 09-May-2021, the patient experienced TACHYCARDIA (Heart rate was Tachycardia at 100 beat per minutes), DIARRHEA (Explosive diarrhea compared to colonoscopy prep/Loose stool every 3 hours) and PYREXIA (Fever at 101/Fever at 100). In May 2021, the patient experienced PAIN IN EXTREMITY (he had pain in his arm of injection). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Elected not to get his 2nd dose because of his side effects for the 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Loose stools, at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Napped for 3 hours), TACHYCARDIA (Heart rate was Tachycardia at 100 beat per minutes), DIARRHOEA (Explosive diarrhea compared to colonoscopy prep/Loose stool every 3 hours), PAIN IN EXTREMITY (he had pain in his arm of injection), FATIGUE (he was very tired), PYREXIA (Fever at 101/Fever at 100) and PRODUCT DOSE OMISSION ISSUE (Elected not to get his 2nd dose because of his side effects for the 1st dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Patient received vaccine on Wednesday. On Thursday and Friday, he was very tired and he napped for 3 hours. Patient  had a fever of 101 On 9 may 2021 and 10 May 2021 and it reduced to 100 on 11-MAY-2021. On 9 May 2021 and 10 May 2021, his heart rate was Tachycardia at 100 beat per minutes, could had possibly been 110 beats per minutes, his resting heart rate is 50 beats per minutes. He called his doctor on 11 May 2021 and they were talks about getting him a pacemaker. Patient stated that he stayed  hydrated and he felt better. This was his 1st vaccine since 1976, he is concerned he had a reaction to the vaccine or component of the vaccine.
Hallucination, shortness of breath, dizziness, weakness, leg edema and low oxygen level. Patient sent to hospital for evaluation and treatment.
Information has been received from a consumer for GARDASIL a Pregnancy Registry product, who in approximately August 2010, was vaccinated IM with the first 0.5 ml dose of GARDASIL (lot# not reported) and in approximately November 2010, the patient was vaccinated IM with the second 0.5 ml dose of GARDASIL (lot# not reported). The consumer stated that she became pregnant around September 2010. LMP (last menstrual period) was approximately in September 2010. EDD (estimated date of delivery) was on 08-JUN-2011 and then she experienced a miscarriage around December 2010. She also stated that she felt fine. Therapy with GARDASIL was discontinued. At the time of the report, the consumer recovered. The consumer did not seek medical attention. Upon internal review, miscarriage was determined to be an other important medical event. Additional information has been requested.
Developed induration and mild erythema with pain on movement in deltoid area overlying Td site. Induration 12x15 cm with erythema 6.5x7.4cm- no fluctuance.
Patient was not feeling well after vaccine administration, and nearly passed out. She was caught by staff before falling, and placed on the floor with legs elevated. 911 was called. She became responsive and stated she felt better. We gave her water, and used ice packs on the back of her head and chest. EMS arrived, and evaluated her. She did not receive additional medical attention.
Body aches, muscle cramps and fever day of vaccination. Upon wakening in morning observed significant swelling of injection site (left shoulder) that extended down arm to hand and fingers, prevailing upon spouse to REMOVE WEDDING BAND USING CUTTING TOOL (side-cutter) to AVOID an emergency room trip.  STRONGLY RECOMMEND ALL VACCINE RECIPIENTS WHOULD BE WARNED ABOUT POTENTIAL HEALTH ISSUES INVOLVING RINGS!!
Had Varivax on 05/15/02. Got case of chickenpox on 05/27/2004. Pt is fine.
This case was reported by a healthcare professional, via a sales representative, and described the occurrence of injection site redness in a subject of unspecified age and gender who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. The subject's relevant medical history and concurrent medications were unknown. On an unspecified date, the subject received unspecified dose of Infanrix (unknown). At an unspecified time after vaccination with Infanrix, the subject experience injection site redness. At the time of reporting the outcome of the event was unspecified.
Starting in 12/2021 I developed a cough, runny nose, chest congestion and achy/cold like symptoms. I took a home test which was negative and, then I went to the pharmacy to get a test, which came back positive. I called my PCP who called me in cough medicine and another pill. Afterwards, I was sick for about a week or two then gradually got better.
This spontaneous report has been received from an office manager refers to an unspecified number of patients of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of PROQUAD (lot # L009209, exp. date on 17-SEP-2016), (strength, route of administration and dose were not provided). There was no concomitant medication reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Delayed the second dose because of the side effect; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Delayed the second dose because of the side effect) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Delayed the second dose because of the side effect). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Delayed the second dose because of the side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided. Patient was due for his second dose on 01Apr2021, but they delayed it because of the side effect from first dose Bell's palsy. The reporter updated that the patient is still recovering and has marginal improvement.
Case number PHEH2016US023490, is an initial spontaneous report received from a healthcare professional on 12 Sep 2016. This report refers to a 55 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with one single dose of FLUVIRIN (batch number: 1618701, expiry date: Apr 2017) at a dose of 0.5 ml, intramuscularly on 09 Sep 2016. It was stated that, the patient received vaccine following 1st time temperature excursion of 52.9 Fahrenheit for 1 hour and 25 minutes. Upon follow up the pharmacist reported, 5 doses were administered following first temperature excursion. FLUVIRIN vaccine underwent second maximum temperature excursion of 46.58 (units unspecified) for 10 mins. No vaccine was administered after second excursion. No adverse event was reported following this medication error (incorrect product storage).
I have had mild reactions to the other COVID-19 vaccines. I woke up that morning with a headache, chills, and lethargic. I also did not have an appetite. By 5/2/2022 I felt better.
received first dose of bnt162b2/ symptoms started on the 26th (26Dec2020) but did not test positive until the 29th (29Dec2020); received first dose of bnt162b2/ symptoms started on the 26th (26Dec2020) but did not test positive until the 29th (29Dec2020); This is a spontaneous report from a Pfizer-sponsored program via a contactable nurse (patient). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number: VAC0002881; expiration date not provided), via an unspecified route of administration on 17Dec2020 at SINGLE DOSE for COVID-19 immunisation. Patient's medical history included hypothyroidism and osteoporosis from unknown dates, both ongoing. Concomitant medications included levothyroxine for hypothyroidism and alendronate sodium (FOSAMAX) for osteoporosis. Patient reported that her symptoms started on the 26th (26Dec2020) but did not test positive until the 29th (29Dec2020). Patient further stated "She received the first dose of Pfizer vaccine last 17Dec (17Dec2020) and 26Dec she was positive with COVID (later clarified of tested positive on 29Dec2020) because of someone else, it seems that it has been transferred, the virus has been transferred to her and then after a few days she got fully recovered, no symptoms, just fully recovered. She is just asking if she really need the second dose of vaccine if she is fully recovered right now." It was reported that patient did not receive treatment for the event. Laboratory test included COVID-19 virus test on 29Dec2020 with positive result. Outcome of the event was recovered.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.
Irregular and fast heart beat 2 hours. Rest and medication.  Follow up: Information unknown.
raised bumps under skin; scared of the possible 2nd vaccine side effects; Rash was on her torso, right thigh, lower back, love handles; not sleeping well; Shingles; "ghost pain" on her left thigh; weird type of pain/pain on her right side; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (weird type of pain/pain on her right side), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SKIN MASS (raised bumps under skin) and SLEEP DISORDER (not sleeping well) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Seasonal allergy.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 30-Jan-2021, the patient experienced PAIN (weird type of pain/pain on her right side). On 02-Feb-2021, the patient experienced HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SLEEP DISORDER (not sleeping well) and RASH (Rash was on her torso, right thigh, lower back, love handles). On 06-Feb-2021, the patient experienced SKIN MASS (raised bumps under skin) and FEAR (scared of the possible 2nd vaccine side effects). At the time of the report, PAIN (weird type of pain/pain on her right side), HERPES ZOSTER (Shingles), PAIN IN EXTREMITY ("ghost pain" on her left thigh), SKIN MASS (raised bumps under skin), SLEEP DISORDER (not sleeping well), FEAR (scared of the possible 2nd vaccine side effects), RASH (Rash was on her torso, right thigh, lower back, love handles) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On multiple unspecified dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 (dose and route unknown, lot# L040053, expiration date: 10-MAY-2017). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
2/2/12 Given Td (L) deltoid IM. Started to get red, itchy, swollen arm 30-60 minutes after injection. Had called clinic 2/6/12 10am to inform of this event. Stated she forgot to tell nurse of latex allergy. Told to alternate hot/cold compresses to site. Use BENADRYL or hydrocortisone as needed for itching.
he was hospitalized because ripped something in his esophagus; started coughing blood; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot/batch number no reported, via an unspecified route of administration on 27Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. Patient reported that he received the 2nd dose of the Pfizer COVID-19 vaccine last 27Jan2021. On Friday 29Jan2021, he was hospitalized because ripped something in his esophagus and started coughing blood. He knows that this is not related to the vaccine but is trying to find out any effects of his prescribed medications with the efficacy of the vaccine. He was prescribed methylprednisolone and Z-pak (Azithromycin) 4mg. He's heard that methylprednisolone can lower the efficacy of the vaccine. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: The reported events ripped something in his esophagus and coughing blood were likely due to diet, and unrelated to the use of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE).
Patient reports that she got her second COVID-19 vaccine dose today at 1100 hours. She states that she woke up from a nap around 1500 hours with constant, midsternal chest pain. Chest pain is non-exertional, non-pleuritic, and non-radiating. She states chest pain is exacerbated by certain movements. Patient endorses lightheadedness.
4 days post vax, the pt complained of severe swelling and pain in left arm. Slightly warm to touch.
Approximately 5 minutes after receiving 2nd moderna vaccine developed mild nausea with no vomiting. On exam noted to have tachycardia to the low 100s, otherwise no other physical exam changes or vital changes. Observed for 1.5hrs with nausea improving, tachycardia resolved. Given zofran x1 and benadryl x1
The lot number for the first dose of vaccine was taken on 04/06/2021is: EW0153, and the lot number for the second dose of vaccine that was taken on 04/25/2021 is: EW0162. He started swelling really bad, and the mortician said all of his organs were very swollen. He was in terrible mental condition, he couldn't think. He had so much swelling that his feet were blue. He was so swollen in his brain he couldn't make basic cognitive  decisions. His chest was so swollen his chest was up to almost double his normal size.  He was under severe mental strain to the point that it took him 14 hours to make a 10 hour drive. He was dealing with maratil strain and shot himself on 05/20/2021.
Patient left the pharmacy and did not report any adverse affects. His wife called the pharmacy the next day and according to her within 20 minutes he had a headache so went to the car. She continued shopping and returned to the car about an hour later. During that time he also threw up. His wife reported that he had not eaten anything that day.
Flu like symptoms; This case was reported by a physician via sales rep and described the occurrence of influenza-like symptoms in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. The patient was treated with ibuprofen and paracetamol (Acetaminophen). On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient experienced flu like symptoms for about 48 hours. The patient used both ibuprofen and actemenophin and resolved on its own. For tolerance to the 2nd dose of Shingrix, US2019AMR194572. The reporter did not agree to follow up from GlaxoSmithKline.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 09-NOV-2016, the patient was vaccinated with incorrectly stored dose of M-M-R II (dose, frequency, route of administration were not reported, lot # M000768, expiration date 05-JAN-2018, status albumin: recombinant human albumin (rHA)) . Concomitant medications were not reported. Administered vaccine experienced the temperature excursion of -14.4 Celsius degrees for 54 minutes. Data logger was involved. No adverse effects reported.    This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained.; Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:
This is a spontaneous report from a contactable consumer (reported for herself). A 58-year-old female patient received the 1st dose of BNT162B2 (Comirnaty, solution for injection, batch/lot# EW0150), via an unspecified route of administration, in left arm, on Apr 6, 2021, at 05:30, single dose, for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing high blood pressure. Concomitant medication included lisinopril for an unspecified indication (start and stop date not reported). The patient previously took cosine and experienced rash. On Apr 8, 2021 (after dose 1), patient experienced mild aching joints. After dose two, she had an extremely aching thumb, wrist and shoulder joints in both arms. No treatment received for the events. She did not have COVID-19 prior to vaccination. She has not tested for COVID-19 post vaccination. The outcome for the events: not recovered. No follow-up attempts possible. No further information expected.
I suffered the worst herpes zoster infection I have ever had. An infection resulted in a scab, below my lower lip,  that was about an inch square. It was HUGE.  I also know that herpes zoster outbreaks after the vaccine are a sign that the vaccine has weakened my immune system.
Joint stiffness and arthritic like pain. Ringing in head, (I having ringing in ears, but this was different) Lasted almost 24 hours. Sore arm from injection.
Possible shingles / breaking out again with shingles; Pain at Injection Site; Spot on Arm /grapefruit-sized spot appeared on arm where vaccine was administered; Joint Pain in Feet / joint pain in both feet; Flu-like Symptoms; Spot around right breast / Stomach Rash tiny bumps; burning of bumps; feeling dehydrated; having no energy; extreme exhaustion /feeling drained; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (her first outbreak of shingles was under her left breast near breast bone).   In October 2019, the patient received the 1st dose of Shingrix (intramuscular). In October 2019, less than 3 weeks after receiving Shingrix, the patient experienced shingles, injection site pain, injection site rash, pain in joint involving lower leg, influenza-like symptoms, rash, burning sensation, feeling abnormal, loss of energy and exhaustion. On an unknown date, the outcome of the shingles, injection site pain, injection site rash, pain in joint involving lower leg, feeling abnormal, loss of energy and exhaustion were unknown and the outcome of the influenza-like symptoms was recovered/resolved and the outcome of the rash and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the shingles, injection site pain, injection site rash, pain in joint involving lower leg, influenza-like symptoms, rash, burning sensation, feeling abnormal, loss of energy and exhaustion to be related to Shingrix.  Additional case details were reported as follows: The patient received 1st dose Shingrix approximately 2 weeks ago in her left arm and that the injection was painful. Approximately 2 days later, caller reports grapefruit-sized spot appeared on arm where vaccine was administered. Also, joint pain in both feet and then flu-like symptoms began. After probing, reporter described flu-like symptoms as feeling drained, having no energy, extreme exhaustion similar to feeling dehydrated. The reporter reported flu-like symptoms would resolve in 2 days, but on the 3rd day it would start again.  Approximately 1.5 weeks following vaccination patient noticed a spot on her right breast followed by a second below breast the next day.  The reporter reported currently no flu-like symptoms the last 2 days, but over these last 2 days she developed a stomach rash described as tiny bumps.  The bumps do not burn like the initial bump and that the initial bump, the bump that lasted the longest was now burning.  The patient was breaking out again with shingles due to similar burning that got worse over time. The reporter reported that her current rash was not coming back in spot she initially had shingles. The reporter described her first shingles rash as starting out by what appeared to be a bug bite, but it did not get better as days went on.  The reporter mentioned shingles got worse as the days went on. The reporter consent to follow up.
Fever, swollen eyes and face, hives all over. Woke up with. Seen in office 10/15/10 and given Prednisone PO. Rx
This spontaneous report was received from a physician assistant via company representative and refers to a currently 25 years old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 02-JUL-2008, the patient was vaccinated with first dose of GARDASIL (strength, dose, frequency, route of administration, lot # and expiration date were not reported). On an unknown date after vaccine administration, the patient's arm hurt and she refused to to receive any other doses. The patient did not seek for medical attention. It was also reported that therapy with GARDASIL was continued. The outcome of pain in extremity and relatedness between the event and GARDASIL was not reported. Additional information has been requested.
Pt came to ER with fever, chills, fatigue, hypoglycemia, and vomiting.  Covid positive.